Randomized, Phase III Trial of Mixed Formulation of Fosrolapitant and Palonosetron (HR20013) in Preventing Cisplatin-Based Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: PROFIT Huaqiang Zhou,Yuanyuan Zhao,Mingjun Zhang, Jun Yao, Shuang Leng,Xiumin Li, Li Lin, Jinping Chen,Songnan Zhang, Xia Qin, Zhiquan Qin,Tienan Yi,Ruoyu Wang, Xiang Li,Yan Yu,Zhenghua Wang,Qinhong Zheng, Jiazhuan Mei,Aimin Zang, Na Li,Fengjun Cao,Ke Cao, Weiwei Li,Yanda Lu,Dang Lin, Yan Zhou,Runxiang Yang,Wenfeng Fang,Ningning Zhou,Yunpeng Yang,Yaxiong Zhang,Gang Chen,Ting Zhou, Xue Yang, Huan Wang, Yujiao Wang,Yan Huang,Li ZhangJournal of clinical oncology official journal of the American Society of Clinical Oncology（2024）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
